SE8206546L - (2,3)-Alkylenedioxy-benzamide derivs. - for use as anxiolytics, antidepressants and antiemetics - Google Patents

(2,3)-Alkylenedioxy-benzamide derivs. - for use as anxiolytics, antidepressants and antiemetics

Info

Publication number
SE8206546L
SE8206546L SE8206546A SE8206546A SE8206546L SE 8206546 L SE8206546 L SE 8206546L SE 8206546 A SE8206546 A SE 8206546A SE 8206546 A SE8206546 A SE 8206546A SE 8206546 L SE8206546 L SE 8206546L
Authority
SE
Sweden
Prior art keywords
alkyl
substd
opt
alkenyl
forms
Prior art date
Application number
SE8206546A
Other languages
Swedish (sv)
Other versions
SE453390B (en
SE8206546D0 (en
Inventor
M Thominet
G Bulteau
J Acher
C Collignon
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/en
Application filed by Ile De France filed Critical Ile De France
Publication of SE8206546D0 publication Critical patent/SE8206546D0/en
Publication of SE8206546L publication Critical patent/SE8206546L/en
Publication of SE453390B publication Critical patent/SE453390B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

of formula (I) and their acid -addn. salts, quat. ammonium salts, oxides and optical isomers are new. In (I), A is 1-3C alkylene opt. substd by 1-4C alkyl, 2-4C alkenyl or 1-4C hydroxyalkyl. R is H, 1-4C alkyl or -B-NR1R2; B is a direct bond or a 1-3C alkylene gp. opt. substd. by 1-4C alkyl or 2-4C alkenyl; R1 is H, 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl, substd. alkyl, or forms a heterocyclic ring with B, and R2 is H, 1-4C alkyl, 2-4C alkenyl or alkynyl, substd. alkyl, an opt. substd. heterocyclic gp., or a phenyl, adamantyl, cycloalkyl, bicycloalkyl or cycloalkenyl gp. bonded directly to the N atom or via an opt. substd. alkylene chain, or NR1R2 is a heterocycle opt. contg. other heteroatoms (including NR", where R" is H- 1-4C alkyl, 2-4C alkenyl or alkynyl, phenyl, benzyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, adamantyl, bicycloalkyl or alkyl substd by OH, SH, acyl, thioacyl, alkoxy or alkylthio). R' is H, 1-4c alkyl, 2-4C alkenyl or alkynyl, adamantyl, pyrimidinyl, pyrazinyl, diazepinyl, quinuclidinyl, azabicycloalkyl, diazabicycloalkyl, bicycloalkyl, or opt. substd. phenyl or aralkyl, or R'+B forms an opt. substd. heterocycle contg. a single N atom, or R'+R1 forms an opt. substd. heterocycle contg. two heteroatoms, X is H, halogen, OH, 1-4C alkoxy, 1-4C alkyl, amino opt. mono- or disubstd. by 1-4C alkyl, acyl, aralkyl, furyl, pyranyl or alkoxycacarbonyl, or forms an A' chain with Y. Y is as defined for X or is NO2, 1-4C alkylsulphonyl, adamantyl-sulphonyl, cycloalkyl sulphonyl or SO2NR3R'; R3 and R4 are H, 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl, phenyl, benzyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, bicycloalkyl, adamantyl, pyrimidinyl, pyrazinyl, or alkyl substd. by OH, SH, acyl, thioacyl, alkoxy or alkylthio, or NR3R4 is an opt. substd. heterocycle opt. congt. another heteroatom; or Y forms an A chain with X or Z. Z is as defined for X or is NO2, or forms an A chain with Y. A is a carbon chain opt. substd. or opt. interrupted by one or more opt. substd. heteroatoms. Cpds. (I) have anxiolytic, antidepressant and antiemetic activity with little or no cataleptic activity. A typical cpd. of N-(1-allyl-2-pyrrolidinylmethyl)-7-methylsulphamoyl-1, 4-benzodioxan-5-carboxamide. In an example, this is prepd. from 1,4-benzodioxan-5-carboxylic acid.

Claims (3)

Patentkrav 1. Substituerade 2,3-alkylen-bis(oxi)bensoesyror for anvandning corn mellanfbreningar till framstallning'av terapeutiskt vardefulla, substituerade 2,3-alkylen-bis-(oxi)-bensamider, k annetecknade av den allmanna formeln: COOS (V) ' X van i A betecknar en alkylenkedja med 1-3 kolatomer, framst di. metylen, etylen eller propylen, X betecknar vate, halogen, hydroxi, alkoxi med 1-4 kolatomer, frAmst dametoxi, etoxi, propoxi, isoproPoxi, butoxi, isobu- toxi'eller t-butoxi, alkyl med 1-4 kolatomer, framstmetyl, etyl, propyl, isopropyl, butyl, isobutyl eller t-butyl, nitro eller acetamino, Y betecknarhalogen, 111110,4 amino eller acetamino, eller Y betecknarsulfonyl mekolatomer, framst ad metylwilfonyl, etylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, isobutylsulfonyl eller t-butylsulfonyl, eller sulfamoyl, C1-C4-alkylsulfamoyl, Ci-C4-dialkylsulfamoy1, adamantylsulfamoyl eller cykloalkylsulfamoyl eller ar bunden till X under bildning av en azimidogrupp, och betecknar vate, halogen, nitro eller.acetamino, eller ar bUnden till Y till alt bilda en azinidogrupp, med de villkoren, altClaims 1. Substituted 2,3-alkylene-bis (oxy) benzoic acids for use as intermediates in the preparation of therapeutically valuable, substituted 2,3-alkylene-bis- (oxy) -benzamides, characterized by the general formula: COOS ( V) 'X van i A represents an alkylene chain having 1-3 carbon atoms, preferably di. methylene, ethylene or propylene, X represents hydrogen, halogen, hydroxy, alkoxy having 1-4 carbon atoms, mainly damethoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy or t-butoxy, alkyl having 1-4 carbon atoms, mainly methyl, ethyl, propyl, isopropyl, butyl, isobutyl or t-butyl, nitro or acetamino, Y represents halogen, 111110.4 amino or acetamino, or Y represents sulfonyl mecol atoms, especially methylwilfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, butylsulfonyl , or sulfamoyl, C 1 -C 4 alkylsulfamoyl, C 1 -C 4 dialkylsulfamoyl, adamantylsulfamoyl or cycloalkylsulfamoyl or are attached to X to form an azimido group, and represent hydrogen, halogen, nitro or acetamino, or are attached to Y to alt. azinido group, with the conditions, alt 1. nal, A betecknar metylen eller etylen och Z betecknar vate. X och Y joke samtidigt betecknar vale,1. nal, A represents methylene or ethylene and Z represents vate. X and Y joke simultaneously denote vale, 2. nal. X och 2 betecknar Irate och A betecknar metylen eller etylen, Y Sr skild frAn en bromatom,2. nal. X and 2 represent Irate and A represents methylene or ethylene, Y is different from a bromine atom, 3. nar X och Z betecknar vateatomer och A betecknar en metylengrUpp, Y joke betecknar nitro, acetamino eller amino, - nar Y och Z betecknar vateatomer och A betecknar en metylengrupp, X joke betecknar en metoxigrupp, saint - nar A betecknar en metylengrupp och Z betecknar X och Y joke-idigt betec'metoxi.3. when X and Z denote hydrogen atoms and A denotes a methylene group, Y joke denotes nitro, acetamino or amino, - when Y and Z denote hydrogen atoms and A denotes a methylene group, s joke denotes a methoxy group, s - when A denotes a methylene group and Z represents X and Y joke-like betec'methoxy.
SE8206546A 1976-08-04 1982-11-17 SUBSTITUTED 2,3-ALKYLENE-BIS (OXI) -BENIC ACIDS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTIC VALUES, SUBSTITUTED 2,3-ALKYLENE-BIS (OXY) -BENZYES SE453390B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (en) 1976-08-04 1976-08-04 NEW 2,3-ALKYLENE BIS (OXY) BENZAMIDE SUBSTITUTES, THEIR DERIVATIVES AND THEIR PREPARATION METHODS

Publications (3)

Publication Number Publication Date
SE8206546D0 SE8206546D0 (en) 1982-11-17
SE8206546L true SE8206546L (en) 1982-11-17
SE453390B SE453390B (en) 1988-02-01

Family

ID=9176558

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7708849A SE440776B (en) 1976-08-04 1977-08-03 SET TO MAKE SUBSTITUTED 2,3-ALKYLENE-BIS (OXO) BENZAMIDES
SE8206546A SE453390B (en) 1976-08-04 1982-11-17 SUBSTITUTED 2,3-ALKYLENE-BIS (OXI) -BENIC ACIDS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTIC VALUES, SUBSTITUTED 2,3-ALKYLENE-BIS (OXY) -BENZYES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7708849A SE440776B (en) 1976-08-04 1977-08-03 SET TO MAKE SUBSTITUTED 2,3-ALKYLENE-BIS (OXO) BENZAMIDES

Country Status (37)

Country Link
JP (1) JPS57167914A (en)
AR (1) AR219709A1 (en)
AT (1) AT358034B (en)
AU (1) AU516033B2 (en)
BE (1) BE857350A (en)
BG (1) BG36496A3 (en)
CA (1) CA1114371A (en)
CH (1) CH629198A5 (en)
CS (1) CS216246B2 (en)
DD (1) DD133237A5 (en)
DE (1) DE2760414C2 (en)
DK (1) DK152366C (en)
EG (1) EG12716A (en)
ES (1) ES461175A1 (en)
FI (1) FI63938C (en)
GR (1) GR61351B (en)
HK (2) HK40382A (en)
HU (1) HU179064B (en)
IE (2) IE45646B1 (en)
IL (2) IL52644A0 (en)
IN (1) IN145473B (en)
LU (1) LU77897A1 (en)
MC (1) MC1154A1 (en)
MW (1) MW2077A1 (en)
NL (1) NL172063C (en)
NO (1) NO152133C (en)
NZ (1) NZ184816A (en)
OA (1) OA05728A (en)
PH (3) PH22114A (en)
PL (1) PL111071B1 (en)
PT (1) PT66865B (en)
RO (1) RO72963A (en)
SE (2) SE440776B (en)
SU (1) SU716523A3 (en)
YU (1) YU40005B (en)
ZA (1) ZA774701B (en)
ZM (1) ZM6077A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (en) * 2015-08-19 2019-01-16 株式会社トクヤマ Manufacturing method of mirtazapine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (en) * 1964-06-09 1967-03-24 Ile De France Nu- (tertiary-aminoalkyl) -methylene dioxybenzamides and their preparation

Also Published As

Publication number Publication date
DK152366B (en) 1988-02-22
BG36496A3 (en) 1984-11-15
IE45646L (en) 1978-02-04
IE45647B1 (en) 1982-10-20
IL52644A0 (en) 1977-10-31
NO152133C (en) 1985-08-07
ZA774701B (en) 1979-01-31
AR219709A1 (en) 1980-09-15
NO772739L (en) 1978-02-07
GR61351B (en) 1978-10-26
NZ184816A (en) 1980-11-14
HU179064B (en) 1982-08-28
YU40005B (en) 1985-06-30
PH17710A (en) 1984-11-19
OA05728A (en) 1981-05-31
MC1154A1 (en) 1978-04-17
SU716523A3 (en) 1980-02-15
IE802409L (en) 1978-02-04
CS216246B2 (en) 1982-10-29
NL172063C (en) 1983-07-01
ATA569677A (en) 1980-01-15
AU516033B2 (en) 1981-05-14
AT358034B (en) 1980-08-11
NO152133B (en) 1985-04-29
CH629198A5 (en) 1982-04-15
SE437027B (en) 1985-02-04
BE857350A (en) 1978-02-01
HK40382A (en) 1982-09-24
SE453390B (en) 1988-02-01
IN145473B (en) 1978-10-21
SE8206546D0 (en) 1982-11-17
HK40482A (en) 1982-09-24
IL66138A0 (en) 1982-09-30
MW2077A1 (en) 1978-12-13
PT66865B (en) 1978-12-29
NL7708616A (en) 1978-02-07
SE440776B (en) 1985-08-19
ES461175A1 (en) 1978-12-01
YU188277A (en) 1983-01-21
AU2750777A (en) 1979-02-08
RO72963A (en) 1981-11-24
DE2760414C2 (en) 1990-05-17
SE7708849L (en) 1978-02-05
PH22114A (en) 1988-06-01
ZM6077A1 (en) 1979-05-21
FI63938B (en) 1983-05-31
EG12716A (en) 1979-09-30
FI63938C (en) 1983-09-12
PT66865A (en) 1977-08-01
FI772362A (en) 1978-02-05
PL200066A1 (en) 1978-09-11
PL111071B1 (en) 1980-08-30
JPS6259090B2 (en) 1987-12-09
IE45646B1 (en) 1982-10-20
LU77897A1 (en) 1978-02-09
CA1114371A (en) 1981-12-15
PH18629A (en) 1985-08-23
NL172063B (en) 1983-02-01
DD133237A5 (en) 1978-12-20
JPS57167914A (en) 1982-10-16
DK346977A (en) 1978-02-05
DK152366C (en) 1988-07-25

Similar Documents

Publication Publication Date Title
SE9302080D0 (en) NEW COMPOUNDS
IE792524L (en) Azabicycloalkyl derivatives.
EP0127902A2 (en) Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
DE3850742D1 (en) New 4-oxobenzotriazines and 4-oxoquinazolines.
KR900009660A (en) New compounds
PE13799A1 (en) DIHYDROPIRONES WITH ANTIVIRAL ACTIVITY
SE8705150D0 (en) NOVEL ANTIARRHYTHMIC AGENTS
SE8206546L (en) (2,3)-Alkylenedioxy-benzamide derivs. - for use as anxiolytics, antidepressants and antiemetics
BG51155A3 (en) Process for preparing a naphthalene derivatives
DE3070847D1 (en) Benzazepine derivatives, process and intermediates for their preparation, their use and pharmaceutical compositions containing them
ES8303415A1 (en) Benzodiazepine compounds and their use as pharmaceuticals.
FR2360305B1 (en)
SE8004129L (en) NEW TETRAHYDROPYRIDIN-4-YL-INDOLD DERIVATIVES AND SALTS THEREOF, PREPARATION AND USE THEREOF AS A MEDICINAL PRODUCT AND COMPOSITIONS CONTAINING THESE COMPOUNDS
FI802384A (en) NYA 3-AMINO-1-BENZOXEPINE DERIVATIVES AND DERAS SALTER; FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT CEILING MODEL INNEHAOLLANDE DESSA FOERENINGAR
JPS5328181A (en) Production of nove substituted 2*33alkylenebis *oxy* benzoic acid
GB1428883A (en) 1,3-benzoxazine and phenyl-alkylamine derivatives
KR890009919A (en) 4-heteroaryl-1,3-benzodiazepine and 2-substituted-α- (heteroaryl) benzeneethanamine, methods of preparation and use thereof as medicaments

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8206546-7

Effective date: 19930307

Format of ref document f/p: F